Abstract
SHIFT trial showed reduced hospital admission rates and mortality with ivabradine, in patients with refractory sustained sinus tachycardia and heart failure with reduced ejection fraction (HFrEF). We present a case of a patient with normal QTc on maximum beta blocker therapy and aggressive diuretics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
